Comparative Effectiveness Research in Inflammatory Bowel Disease

被引：1

作者：

Slattery, Eoin ^{[1
]}

Harewood, Gavin C. ^{[1
]}

机构：

[1] Beaumont Hosp, Dept Gastroenterol, Dublin 9, Ireland

来源：

INFLAMMATORY BOWEL DISEASES | 2011年 / 17卷 / 06期

关键词：

TRIALS;

D O I：

10.1002/ibd.21693

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：E46 / E47

页数：2

共 20 条

[1] Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease. [J].

Colombel, Jean Frederic ;

Sandborn, William J. ;

Reinisch, Walter ;

Mantzaris, Gerassimos J. ;

Kornbluth, Asher ;

Rachmilewitz, Daniel ;

Lichtiger, Simon ;

D'Haens, Geert ;

Diamond, Robert H. ;

Broussard, Delma L. ;

Tang, Kezhen L. ;

van der Woude, C. Janneke ;

Rutgeerts, Paul .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (15) :1383-1395

[2] Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial [J].

Colombel, Jean-Frederic ;

Sandborn, William J. ;

Rutgeerts, Paul ;

Enns, Robert ;

Hanauer, Stephen B. ;

Panaccione, Remo ;

Schreiber, Stefan ;

Byczkowski, Dan ;

Li, Ju ;

Kent, Jeffrey D. ;

Pollack, Paul F. .

GASTROENTEROLOGY, 2007, 132 (01) :52-65

[3] Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial [J].

D'Haens, G ;

Van Deventer, S ;

Van Hogezand, R ;

Chalmers, D ;

Kothe, C ;

Baert, F ;

Braakman, T ;

Schaible, T ;

Geboes, K ;

Rutgeerts, P .

GASTROENTEROLOGY, 1999, 116 (05) :1029-1034

[4] Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease:: an open randomised trial [J].

D'Haens, Geert ;

Baert, Filip ;

van Assche, Gert ;

Caenepeel, Philip ;

Vergauwe, Philippe ;

Tuynman, Hans ;

De Vos, Martine ;

van Deventer, Sander ;

Stitt, Larry ;

Donner, Allan ;

Vermeire, Severine ;

Van De Mierop, Frank J. ;

Coche, Jean-Charles R. ;

van der Woude, Janneke ;

Ochsenkuehn, Thomas ;

van Bodegraven, Ad A. ;

van Hootegem, Philippe P. ;

Lambrecht, Guy L. ;

Mana, Fazia ;

Rutgeerts, Paul ;

Feagan, Brian G. ;

Hommes, Daniel .

LANCET, 2008, 371 (9613) :660-667

[5] Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial [J].

Hanauer, SB ;

Sandborn, WJ ;

Rutgeerts, P ;

Fedorak, RN ;

Lukas, M ;

Macintosh, D ;

Panaccione, R ;

Wolf, D ;

Pollack, P .

GASTROENTEROLOGY, 2006, 130 (02) :323-332

[6] Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial [J].

Hanauer, SB ;

Feagan, BG ;

Lichtenstein, GR ;

Mayer, LF ;

Schreiber, S ;

Colombel, JF ;

Rachmilewitz, D ;

Wolf, DC ;

Olson, A ;

Bao, WH ;

Rutgeerts, P .

LANCET, 2002, 359 (9317) :1541-1549

[7] Association between competing interests and authors' conclusions: epidemiological study of ramdomised clinical trials published in the BMJ [J].

Kjaergard, LL ;

Als-Nielsen, B .

BMJ-BRITISH MEDICAL JOURNAL, 2002, 325 (7358) :249-252

[8] Infliximab plus azathioprine for steroid-dependent Crohn's disease patients:: A randomized placebo-controlled trial [J].

Lémann, M ;

Mary, JY ;

Duclos, B ;

Veyrac, M ;

Dupas, JL ;

Delchier, JC ;

Laharie, D ;

Moreau, J ;

Cadiot, G ;

Picon, L ;

Bourreille, A ;

Sobahni, I ;

Colombel, JF .

GASTROENTEROLOGY, 2006, 130 (04) :1054-1061

[9] Infliximab for the treatment of fistulas in patients with Crohn's disease [J].

Present, DH ;

Rutgeerts, P ;

Targan, S ;

Hanauer, SB ;

Mayer, L ;

van Hogezand, RA ;

Podolsky, DK ;

Sands, BE ;

Braakman, T ;

DeWoody, KL ;

Schaible, TF ;

van Deventer, SJH .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (18) :1398-1405

[10] Understanding controlled trials -: What are pragmatic trials? [J].

Roland, M ;

Torgerson, DJ .

BRITISH MEDICAL JOURNAL, 1998, 316 (7127) :285-285

← 1 2 →